Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 New Entrants companies in Nicotinamide mononucleotide
by Most Patent Filing In 1 Year in the China in 2020

The Nicotinamide mononucleotide top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 1 Year Nicotinamide mononucleotide New Entrants in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Nicotinamide mononucleotide ("NMN", "NAMN", and "β-NMN") is a nucleotide derived from ribose and nicotinamide. Like nicotinamide riboside, NMN is a derivative of niacin, and humans have enzymes that can use NMN to generate nicotinamide adenine dinucleotide (NADH).
Page generation time: Jun 19 2025